ArticleEuropean journal of medical research2025
Machine learning and nomogram prediction model to explore the relationship between monocyte-to-high-density lipoprotein cholesterol ratio and asthma: results from the NHANES 2001-2018.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAsthma is a prevalent chronic respiratory disease with significant morbidity and healthcare burden. Identifying novel biomarkers for asthma risk prediction is crucial for early intervention and personalized management. The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) has emerged as a potential inflammatory marker in various chronic diseases. This study aimed to investigate the association between MHR and asthma risk using data from the National Health and Nutrition Examination Survey (NHANES) and to develop a predictive model for asthma risk incorporating MHR and other clinical variables.
methodsData from NHANES (2001-2018) were used. Weighted logistic regression was employed to assess the relationship between MHR and asthma risk. Participants were randomly divided into training (70%) and validation (30%) cohorts. The Boruta algorithm was used to evaluate the training cohort, select the best model, and identify potential confounding factors. A nomogram-based predictive model was constructed using variables selected by the Boruta algorithm [smoke, age, hypertension, cardiovascular disease (CVD), marital status, gender, race, poverty-income ratio (PIR), body mass index (BMI), cancer, education, diabetes, and MHR]. The model's performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA) curves. The variables selected by Boruta algorithm are included in the machine learning (ML) model for analysis. SHAP (SHapley Additive exPlanations) analysis was performed to assess the contribution of each variable.
resultsA total of 28,855 participants were included after excluding those with missing data. MHR was positively associated with asthma incidence (P < 0.05). The Boruta algorithm achieved an AUC of 0.64 in the validation cohort. Among the ML models, the Xgboost model demonstrated the best performance with an AUC of 0.640 (95% CI 0.623-0.656). SHAP analysis identified CVD as the most influential factor, followed by age, BMI, PIR, and gender.
conclusionsThis study demonstrates a positive association between the MHR and asthma risk, indicating a significant cross-sectional relationship. The nomogram-based predictive model incorporating MHR and other clinical variables showed moderate discriminative ability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.